Cubist Systematic Strategies, LLC Aprea Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$0.62 - $1.94 $12,754 - $39,909	-20,572 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.59 - $3.16 $32,709 - $65,007	20,572 New	20,572 $38,000
Q1 2021 May 17, 2021	SELL	$4.73 - $8.15 $51,093 - $88,036	-10,802 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.92 - $30.67 $43,704 - $272,441	8,883 Added 462.9%	10,802 $53,000
Q3 2020 Nov 16, 2020	BUY	$21.66 - $38.86 $41,565 - $74,572	1,919 New	1,919 $46,000

Others Institutions Holding APRE

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.